+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years - 75Years
All Genders
ID05511909

Phase II Study Evaluating Buspirone, Lofexidine, and Placebo for Opioid Withdrawal and Craving During a Residential Opioid Taper

Led by University of Maryland, Baltimore · Updated on 2026-08-24

100

Participants Needed

1

Research Sites

8 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are conducting a Phase II randomized clinical trial to study the effects of buspirone on opioid withdrawal and craving among adults with opioid use disorder OUD. This trial aims to evaluate buspirones ability to reduce withdrawal symptoms and craving, improve treatment retention, and lower relapse rates. The study compares buspirone with lofexidine and placebo during a standardized stepwise opioid taper in a residential setting. Participants will be randomly assigned to one of three groups opioid taper with buspirone, opioid taper with lofexidine, or opioid taper with placebo. Each medication starts two days before the opioid taper and continues through the taper and a post-taper observation period, lasting about 10 to 12 days. After tapering, participants may start long-term treatments like buprenorphine or extended-release naltrexone or receive referrals to other treatment programs. Throughout the study, participants complete daily questionnaires on withdrawal and craving symptoms. Craving is also measured during specific tasks in residential and outpatient phases. Safety and acceptability are monitored through adverse event reports, ECG evaluations, and participant feedback. The primary outcome is change in opioid withdrawal symptoms, with secondary outcomes including craving levels, adverse events, and medication acceptability. The total participation lasts about 10 to 12 days.

CONDITIONS

Brief Title

Evaluating Buspirone to Treat Opioid Withdrawal

Research Team

C

Cecilia Bergeria, Ph.D.

C

Caitlyn Grubb, B.S.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here